Genentech at PEGS Europe 2026
Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website
Genentech brings 4 presentations to PEGS Europe 2026 in Lisbon. Its program spans antibody optimisation and T cell bispecific therapy, including tumour-targeted 4-1BB versus CD28 co-stimulation in solid tumours. Other topics are a modular platform for sterically masked cytokines and AI reading of label-free imaging in T cell killing assays.
| Organization | PEGS Europe 2026 Attendance |
|---|---|
Genentech South San Francisco, CA | |
Roche group biotechnology company discovering and developing antibody and protein medicines in oncology, immunology and other areas. | Talk Tue Nov 17 11:45am–12:15pm Talk Wed Nov 18 2:05pm–2:35pm Talk Wed Nov 18 6:30pm–7:00pm |
Instantly find 20 buyers from Genentech
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction